Venn Life Sciences Grows CRO Business in Europe
Venn Life Sciences, a CRO providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the recent acquisition of two European CROs.
Venn Life Sciences, a CRO providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the recent acquisition of two European CROs. Venn acquired German CRO CRM clinical trials and Medevol Clinical Services in the UK. Venn has operations in France, Ireland, the Netherlands, Russia, the UK and a branch office in Switzerland. It also has a Clinical Resourcing business placing experienced clinical teams and individuals on projects throughout Europe.
Founded in 1996, CRM is a full-service CRO based in Rheinbach, Germany, specializing in Phases II-IV. CRM has extensive experience in dermatology, pneumology and urology, and its suite of services include initial and ongoing training for study nurses, investigators and trial teams in the areas of quality, planning andmonitoring of clinical studies.
The second acquisition is Medevol, a CRO in the UK clinical trials market since 2001, conducting full-service studies for global pharmaceutical and biotechnology companies across Phases II - IV. With extensive therapeutic experience across a broad range of indications, Medevol also provide contract staffing solutions. The company is based in Belfast.
You can read the full release here.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
